The test library
Heart Rate Variability
The small, constant variation in the time between heartbeats — and what it says about how much reserve the nervous system has.
For patients
What it feels like
You lie still and breathe normally for several minutes while a sensor records your pulse. That is the entire procedure. Then you may be asked to breathe slowly in time with a prompt while the recording continues.
What it measures
A healthy heart does not beat like a metronome. The interval between beats varies constantly, by small amounts, as the two halves of the autonomic nervous system adjust to breathing, posture and blood pressure. That variation is a sign of a responsive system.
When the system loses flexibility — through nerve damage, illness, chronic stress, or medication — the intervals become more uniform. Counterintuitively, a heart that beats with very little variation is usually the less healthy one.
What a number does and does not mean
There is no single good value. Heart rate variability falls with age, differs between people, and moves substantially with one bad night of sleep, a glass of wine, a cup of coffee or a hard training session. A single reading in isolation is close to meaningless.
What is meaningful is the comparison — your reading against your own reading, taken under the same conditions. That is why the preparation instructions are strict. How to prepare.
Why it is measured here
Because it is the cheapest, quickest window on the autonomic system, and because it can be repeated as often as you like. Autonomic symptoms.
For physicians
What is measured
Analysis of NN or RR interval series derived from the photoplethysmographic or electrocardiographic signal, in both the time domain and the frequency domain, at rest and during standardized challenges. The correlation between photoplethysmography-derived and electrocardiogram-derived intervals is high, which is what makes optical acquisition practical in an office setting.
Reading it without over-reading it
Three constraints govern useful interpretation.
- Acquisition conditions dominate the signal. Posture, respiratory rate, time of day, prandial state, caffeine, nicotine, alcohol, sleep and recent exercise all move the indices materially. Standardize them or do not compare.
- Age and medication set the expected range. Beta-blockade, anticholinergic burden and antiarrhythmics all alter the result, in different directions.
- A single low value is a hypothesis. Repeat under controlled conditions before it enters the problem list.
What it is good for
Trend, not diagnosis. Serial measurement in a patient whose management is changing — glycemic control, deconditioning, medication reduction, sleep treatment — is where the measurement earns its place. Cross-sectional comparison against a population norm is where it is most often misused.
Where it fits
A component of autonomic testing, acquired from the same pulse waveform and read alongside the reflex battery.
Evidence and limitations
Written for a reader who wants the literature rather than the summary. Where the evidence is thin we say so and give both sides, and where a claim is mechanistic rather than demonstrated we label it as such.
Mechanism
Sinus rhythm is not regular. Vagal outflow modulates the sinoatrial node beat by beat, predominantly at respiratory frequencies, while sympathetic outflow acts more slowly. Analysis of the interval series in the time domain and the frequency domain separates those contributions imperfectly but usefully. Loss of variability reflects loss of the modulating traffic — which is why a metronomically regular heart is the abnormal one.
What the evidence shows
Heart rate variability is not a standalone diagnosis; it is one component of the graded criteria used to define cardiac autonomic neuropathy. Under the Toronto Consensus scheme, one abnormal cardiovagal test identifies possible or early disease, two or more identify definite disease, and orthostatic hypotension alongside abnormal heart rate testing identifies advanced disease.
The prognostic weight sits on that composite rather than on any single index. A meta-analysis of 26 studies found a pooled relative risk of future cardiovascular events of 3.16 (95% CI 2.42 to 4.13) and of all-cause mortality of 3.17 (95% CI 2.11 to 4.78) in patients with cardiac autonomic neuropathy versus those without, with a stronger association for definite than for possible disease.
Limitations of that evidence
- No universally applicable normal range. Variability falls with age, differs markedly between individuals, and is altered by beta-blockade, anticholinergics and antiarrhythmics.
- Acquisition conditions dominate. Posture, respiratory rate, recording length, prandial state, caffeine, nicotine, alcohol, sleep and recent exercise all move the indices materially. Comparisons across methods are not valid.
- Most outcome data comes from diabetes cohorts, and from batteries rather than from resting variability alone.
- Consumer devices are not clinical devices. Different sensors, sampling, artifact rejection, algorithms and recording windows produce numbers that are internally consistent and mutually incomparable.
What remains uncertain
Whether serial heart rate variability should be used to titrate treatment is unresolved. It is plausible — the measurement is cheap, repeatable and responsive — and it has not been tested as a management target in a way that would justify presenting it as one. On this site it is used for what the evidence supports: characterizing autonomic function as part of a battery, and tracking an individual against their own baseline under controlled conditions.
Talk to someone about testing
Tell us what you are trying to find out and we will explain which Measura assessments answer that question, what each one involves, and how the results are reviewed with a clinician.
4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Call us with clinical detail.
Common questions
What is a good heart rate variability score?
There is no single good number — it depends on age, medication and what you did yesterday. What the number means.
My smartwatch gives me a different number. Why?
Different acquisition, different algorithm, different conditions. Comparisons are only valid within one method. Read more.
Can I improve it?
Sleep, alcohol reduction, aerobic conditioning and glycemic control all move it, and it can be remeasured to see whether they did. Repeat intervals.
References
- Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Toronto Consensus Panel on Diabetic Neuropathy. Diabetes/Metabolism Research and Reviews. 2011;27(7):639–653. doi:10.1002/dmrr.1239
- Chowdhury M, Nevitt S, Eleftheriadou A, et al. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis. BMJ Open Diabetes Research & Care. 2021;9(2):e002480. doi:10.1136/bmjdrc-2021-002480
Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed .